Ms. Susan Jane Searle is Chairman at Woodford Patient Capital Trust Plc, Non-Executive Chairman at Mercia Technologies Plc, Chief Executive Officer at Imperial College Innovations Ltd. and an Advisor at Arcapita Venture Capital.
She is on the Board of Directors at Horizon Discovery Group Plc, QinetiQ Group Plc, Benchmark Holdings Plc and SS Businesses Ltd.
Ms. Searle was previously employed as a Trustee by British Eye Research Foundation, Chief Executive Officer by Imperial Innovations Investment Management Ltd., Executive Director & Head-Investor Relations by Imperial Innovations Group Plc, a Principal by Bank of Nova Scotia, Non-Executive Director by Evo Electric Ltd., Non-Executive Director by Plaxica Ltd., a Principal by Shell Chemicals Ltd., and a Principal by Signet Group Ltd.
She also served on the board at Brightstar Financial Management Ltd., i2 India Ventures Pvt Ltd., Imperial College Co. Maker Ltd., Imperial Innovations Investments Ltd., Imperial Innovations Ltd. and Thiakis Ltd.
Ms. Searle received her graduate degree from the University of Oxford and a graduate degree from Exeter College.